Comment on

• Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations.

  Phillips KA, Nichol K, Ozcelik H, Knight J, Done SJ, Goodwin PJ, Andrulis IL. Phillips KA, et al. J Natl Cancer Inst. 1999 Mar 3;91(5):469-73. doi: 10.1093/jnci/91.5.469. J Natl Cancer Inst. 1999. PMID: 10070948
• Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers.

  Porter PL, El-Bastawissi AY, Mandelson MT, Lin MG, Khalid N, Watney EA, Cousens L, White D, Taplin S, White E. Porter PL, et al. J Natl Cancer Inst. 1999 Dec 1;91(23):2020-8. doi: 10.1093/jnci/91.23.2020. J Natl Cancer Inst. 1999. PMID: 10580027
• Biologic characteristics of interval and screen-detected breast cancers.

  Gilliland FD, Joste N, Stauber PM, Hunt WC, Rosenberg R, Redlich G, Key CR. Gilliland FD, et al. J Natl Cancer Inst. 2000 May 3;92(9):743-9. doi: 10.1093/jnci/92.9.743. J Natl Cancer Inst. 2000. PMID: 10793111